These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 17589370)

  • 21. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
    Haney M; Malcolm RJ; Babalonis S; Nuzzo PA; Cooper ZD; Bedi G; Gray KM; McRae-Clark A; Lofwall MR; Sparenborg S; Walsh SL
    Neuropsychopharmacology; 2016 Jul; 41(8):1974-82. PubMed ID: 26708108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users.
    Ramaekers JG; Theunissen EL; de Brouwer M; Toennes SW; Moeller MR; Kauert G
    Psychopharmacology (Berl); 2011 Mar; 214(2):391-401. PubMed ID: 21049267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
    Bedi G; Cooper ZD; Haney M
    Addict Biol; 2013 Sep; 18(5):872-81. PubMed ID: 22260337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
    Herrmann ES; Cooper ZD; Bedi G; Ramesh D; Reed SC; Comer SD; Foltin RW; Haney M
    Psychopharmacology (Berl); 2016 Jul; 233(13):2469-78. PubMed ID: 27085870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial.
    Ellis RJ; Toperoff W; Vaida F; van den Brande G; Gonzales J; Gouaux B; Bentley H; Atkinson JH
    Neuropsychopharmacology; 2009 Feb; 34(3):672-80. PubMed ID: 18688212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.
    Cooper ZD; Comer SD; Haney M
    Neuropsychopharmacology; 2013 Sep; 38(10):1984-92. PubMed ID: 23609132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of tiagabine maintenance on cannabis effects and related behaviors in daily cannabis users.
    Wesley MJ; Westgate PM; Stoops WW; Kelly TH; Hays LR; Lile JA
    Exp Clin Psychopharmacol; 2018 Jun; 26(3):310-319. PubMed ID: 29863387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Brooks DJ; Pavlicova M; Cheng W; Nunes EV
    Drug Alcohol Depend; 2011 Jul; 116(1-3):142-50. PubMed ID: 21310551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bupropion SR worsens mood during marijuana withdrawal in humans.
    Haney M; Ward AS; Comer SD; Hart CL; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 2001 May; 155(2):171-9. PubMed ID: 11401006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute Effects of Smoked and Vaporized Cannabis in Healthy Adults Who Infrequently Use Cannabis: A Crossover Trial.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    JAMA Netw Open; 2018 Nov; 1(7):e184841. PubMed ID: 30646391
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers.
    Lundahl LH; Greenwald MK
    Drug Alcohol Depend; 2015 Apr; 149():187-93. PubMed ID: 25725933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
    Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
    Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers.
    Cooper ZD; Foltin RW; Hart CL; Vosburg SK; Comer SD; Haney M
    Addict Biol; 2013 Nov; 18(6):993-1002. PubMed ID: 22741619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smoked marijuana attenuates performance and mood disruptions during simulated night shift work.
    Keith DR; Gunderson EW; Haney M; Foltin RW; Hart CL
    Drug Alcohol Depend; 2017 Sep; 178():534-543. PubMed ID: 28728115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for pain.
    Issa MA; Narang S; Jamison RN; Michna E; Edwards RR; Penetar DM; Wasan AD
    Clin J Pain; 2014 Jun; 30(6):472-8. PubMed ID: 24281276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol.
    Levin FR; Mariani JJ; Brooks DJ; Xie S; Murray KA
    Drug Alcohol Depend; 2010 Jan; 106(1):65-8. PubMed ID: 19733018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abstinence symptoms following smoked marijuana in humans.
    Haney M; Ward AS; Comer SD; Foltin RW; Fischman MW
    Psychopharmacology (Berl); 1999 Feb; 141(4):395-404. PubMed ID: 10090647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Field Sobriety Tests for Identifying Drivers Under the Influence of Cannabis: A Randomized Clinical Trial.
    Marcotte TD; Umlauf A; Grelotti DJ; Sones EG; Mastropietro KF; Suhandynata RT; Huestis MA; Grant I; Fitzgerald RL
    JAMA Psychiatry; 2023 Sep; 80(9):914-923. PubMed ID: 37531115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations.
    Huestis MA; Elsohly M; Nebro W; Barnes A; Gustafson RA; Smith ML
    Ther Drug Monit; 2006 Aug; 28(4):540-4. PubMed ID: 16885722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.